Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002460:Cell Line; D004147:Dioxins / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006968:Hypersensitivity, Delayed; D007108:Immune Tolerance / Q000187:drug effects*; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*
D004147:Dioxins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D000072317:Polychlorinated Dibenzodioxins